Embera NeuroTherapeutics, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Embera NeuroTherapeutics, Inc.
Antibiotic incentives, vaccine strategies, drug pricing, patent updates and more hot topics from the Biotechnology Innovation Organization's recent annual conference.
Biopharma, medtech and diagnostics start-ups raised a whopping 51% more Series A money in the first half of 2015 than during the same period last year, and the number of deals was way up too.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced March through April 2015.
In Vivo briefly summarizes the technologies of these recently founded companies: Advanced Tissue Therapies, Cequent Pharmaceuticals, Embera NeuroTherapeutics, Freedom Meditech, Molteni Therapeutics, and SpheroSense Technologies.
- Specialty Pharmaceuticals